Neural network measures MS disease progression

Article

The percentage of brain volume is an important marker of disease progression in multiple sclerosis. Researchers have developed a prototype neural network-based quantification system to measure this important benchmark by computer-assisted segmentation of multispectral MR imaging data.

The percentage of brain volume is an important marker of disease progression in multiple sclerosis. Researchers have developed a prototype neural network-based quantification system to measure this important benchmark by computer-assisted segmentation of multispectral MR imaging data.

Dr. Axel Wismueller of Ludwig Maximilians University in Munich performed MR exams in six women with relapsing-remitting MS. The neural network computed the percentage of brain volume by automatic cerebrospinal fluid segmentation. The voxel-specific gray-level intensity spectrum forms a seven-dimensional feature vector, which is classified by the neural network as either belonging to CSF or not. Findings were reported at the 2005 European Congress of Radiology.

The neural network-based computation significantly outperformed the conventional angle-image method. Specifically, the neural network performed better by retrieving only T2-weighted and perfusion/diffusion-weighted signals, thereby avoiding misclassifications in white matter lesions that are difficult to distinguish from CSF.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.